Key result
MTHSWD plus iPS-CMs improves heart function and reduces infarct size in a mouse MI model.
Why the study?
To evaluate whether modified Taohong Siwu decoction combined with human induced pluripotent stem cell-derived cardiomyocyte transplantation promotes cardiac function after myocardial infarction and explore potential mechanisms.
Does modified Taohong Siwu decoction combined with iPS-CMs transplantation improve heart repair in a myocardial infarction mouse model?
Does modified Taohong Siwu decoction combined with iPS-CMs transplantation improve heart repair in a myocardial infarction mouse model?
The combination of modified Taohong Siwu decoction and iPS-CMs transplantation improves cardiac function and repair in a mouse model of myocardial infarction.
May support combined MTHSWD+iPS-CMs therapy in MI mice; extends preclinical RCT data but leaves open human translation.
Objective: This study aimed to study whether modified Taohong Siwu decoction (MTHSWD) combined with human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs) transplantation can promote cardiac function in myocardial infarction (MI) nude mouse model and explore its possible mechanism. Methods: The MI mouse model was established by the ligation of left anterior descending coronary artery. After 4 weeks of gavage of MTHSWD combined with iPS-CMs transplantation, the changes in heart function of mice were examined by echocardiography. The histological changes were observed by Masson's trichrome staining. The survival and differentiation of transplanted cells were detected by double immunofluorescence staining of human nuclear antigen (HNA) and cardiac troponin T (cTnT). The number of c-kit-positive cells in the infarct area were evaluated by immunofluorescent staining. The levels of stromal cell-derived factor 1 (SDF-1), stem cell factor (SCF), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor in infarcted myocardium tissues were detected by ELISA. Results: MTHSWD combined with iPS-CMs transplantation can improve the heart function of MI mice, reduce the infarct size and collagen deposition in infarct area. By immunofluorescence double-label detection of HNA and cTnT, it was found that MTHSWD combined with iPS-CMs transplantation can improve the survival and maturation of iPS-CMs. In addition, MTHSWD combined with iPS-CMs transplantation can activate more endogenous c-kit positive cardiac mesenchymal cells, and significantly increase the content of SDF-1, SCF and VEGF in myocardial tissues. Conclusions: The combination of MTHSWD with iPS-CMs transplantation promoted cardiac function of nude mice with MI by improving the survival and maturation of iPS-CMs in the infarct area, activating the endogenous c-kit positive cardiac mesenchymal cells, and increasing paracrine.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2024) studied Myocardial infarction. Modified Taohong Siwu decoction (MTHSWD) combined with human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs) transplantation was evaluated on Heart function, infarct size, and collagen deposition. MTHSWD combined with iPS-CMs transplantation improved heart function, reduced infarct size, and enhanced survival and maturation of iPS-CMs in a nude mouse model of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: